Thus, targeting the TCF7L2/β-catenin interaction might be a promising way to cut fuel supply for pancreatic cancer, since cancer cell metabolism has been proven to be a new target for improving cancer cell malignancies26–30. Here, TCF7L2 is linked to familial pancreatic carcinoma.